In ACT, autologous TILs are initially isolated from an existing tumor mass, co-cultured with IL2 to grow ex vivo [229] and subpopulations of these proliferating cells are tested in vitro against the patient’s original tumor. The gene discussed is IL2; the disease is neoplasm.